BALANCE SHEET COMPONENTS (Tables)

12 Months Ended

Dec. 31, 2022

Balance Sheet Related Disclosures [Abstract]

Schedule of Inventory, net

Inventory consisted of the following:

(In thousands)	December 31, 2022
Raw materials	$	5,757
Work-in-process		25,052
Finished goods		25,088
Total inventory	$	55,897

Schedule of Other Accrued Liabilities

Other accrued liabilities consisted of the following:

	December 31,
(In thousands)	2022		2021
Accrued contract manufacturing expenses	$	8,382	$	—
Accrued clinical expenses		692		—
Accrued research expenses		349		—
Accrued professional services		3,977		894
Current portion of lease liabilities		1,316		106
Current portion of deferred royalty obligation		2,639		—
Accrued license fees and royalties		943		—
Other		2,909		9
Total other accrued liabilities	$	21,207	$	1,009

Schedule of Other Long-term Liabilities

Other long-term liabilities consisted of the following:

(In thousands)	December 31, 2022
Long-term portion of deferred royalty obligation	$	67,947
Long-term portion of lease liabilities		2,376
Contingent value rights liability		595
Total other long-term liabilities	$	70,918